; (G) third-party payers and managed-care organizations; and (H) related commercial industries. (2) Policy development The Administrator of the Health Resources and Services Administration, the Director of the Centers for Disease Control and Prevention, and the Director of the National Institutes of Health shall coordinate and collaborate on recommendations for policy development at the Federal and State levels and with the private sector, including consumer, medical, and other health and education professional-based organizations, with respect to newborn and infant hearing screening, evaluation, diagnosis, and intervention programs and systems. (3) State early detection, diagnosis, and intervention programs and systems; data collection The Administrator of the Health Resources and Services Administration and the Director of the Centers for Disease Control and Prevention shall coordinate and collaborate in assisting States— (A) to establish newborn, infant, and young childhood hearing screening, evaluation, diagnosis, and intervention programs and systems under subsection (a); and (B) to develop a data collection system under subsection (b). (d) Rule of construction; religious accommodation Nothing in this section shall be construed to preempt or prohibit any State law, including State laws that do not require the screening for hearing loss of newborns, infants, or young children of any parent that objects to the screening on the grounds that such screening conflicts with the parent’s religious beliefs. (e) Definitions For purposes of this section: (1) The term audiologic , when used in connection with evaluation, means procedures— (A) to assess the status of the auditory system; (B) to establish the site of the auditory disorder, the type and degree of hearing loss, and the potential effects of hearing loss on communication